CanadaJAMP-Risperidone 0.25 mg tablets (DIN 02359529) from JAMP Pharma, lots ENN063001 and ENN062001, are affected. They were recalled because impurities were out of specification during stability. Verify if your product is one of these lots, consult your healthcare provider before stopping use, contact the recalling firm with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: JAMP Pharma Corporation, 1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3.
How to identify it
Brand: JAMP; Product Name: JAMP-RISPERIDONE; Market Authorization: DIN 02359529; Dosage Form: Tablet; Strength: Risperidone 0.25mg; Lot: ENN063001, ENN062001
The hazard
The impurities are out of specification during stability in the affected lots.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)